Clinical Trials Logo

Clinical Trial Summary

A study to increase the safety of polyvalent antivenom involving 1000 patients in three centres: low dose adrenaline, promethazine, & hydrocortisone (alone and in combination) to prevent acute adverse reactions to antivenom in people bitten by snakes: randomised, double blind, placebo-controlled trial.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00270777
Study type Interventional
Source University of Kelaniya
Contact
Status Completed
Phase Phase 4
Start date March 2005
Completion date April 2008

See also
  Status Clinical Trial Phase
Completed NCT03326492 - Evaluation of Anti-venoms Serum in Africa
Terminated NCT02570347 - Routine Antibiotic vs. Directed Antibiotic Treatment in Snake Bite Phase 4
Completed NCT03890016 - Study Comparing Modified Lee White Clotting Time Against Twenty Minute Whole Blood Clotting Test in Snakebite Victims
Withdrawn NCT02694952 - Non-inferiority Trial of Two Snake Antivenoms in CAR (PAVES) N/A
Completed NCT04520282 - Hemostatic Variables In Snakebite Study
Completed NCT01864200 - Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation Phase 4
Completed NCT04470791 - Cryotherapy as a Coadjuvant in Crotaline Snakebite Management With Antivenom. N/A